國立虎尾科技大學 |

登入

回首頁

Resistance to ibritumomab in lymphoma

SpringerLink (Online service)

Resistance to ibritumomab in lymphoma

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Resistance to ibritumomab in lymphoma/ edited by Makoto Hosono, Jean-Francois Chatal.
其他作者:	Hosono, Makoto.
出版者:	Cham :Springer International Publishing : : 2018.,
面頁冊數:	xiii, 158 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Lymphomas - Treatment. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-78238-6
ISBN:	9783319782386

Resistance to ibritumomab in lymphoma
Resistance to ibritumomab in lymphoma[electronic resource] /edited by Makoto Hosono, Jean-Francois Chatal. - Cham :Springer International Publishing :2018. - xiii, 158 p. :ill., digital ;24 cm. - Resistance to targeted anti-cancer therapeutics,v.182196-5501 ;. - Resistance to targeted anti-cancer therapeutics ;v.4..

Clinical Use and Efficacy of Ibritumomab in B-cell Lymphoma -- Biology and Pathology of B-cell lymphoma -- Resistance to Y-90 Ibritumomab Tiuxetan Therapy -- Features of Ibritumomab as Radionuclide Therapy -- Radiological Evaluation of Response and Resistance of Ibritumomab -- Characteristics of Ibritumomab as Radionuclide Therapy Agent -- Resistance and Heterogeneity of Intratumoral Antibody Distribution -- Radiation Dosimetry in Ibritumomab Therapy -- Combining RAIT and immune-based therapies to overcome resistance in cancer? -- Prospects for enhancing efficacy of radioimmunotherapy -- Index.

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.

ISBN: 9783319782386

Standard No.: 10.1007/978-3-319-78238-6doiSubjects--Topical Terms:

778114
Lymphomas
--Treatment.

LC Class. No.: RC280.L9 / R475 2018

Dewey Class. No.: 616.99446

Resistance to ibritumomab in lymphoma
LDR:01953nam a2200325 a 4500 001 925560
003 DE-He213
005 20181105143639.0
006 m d
007 cr nn 008maaau
008 190625s2018 gw s 0 eng d
020 $a 9783319782386 $q (electronic bk.)
020 $a 9783319782379 $q (paper)
024 7 $a 10.1007/978-3-319-78238-6 $2 doi
035 $a 978-3-319-78238-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L9 $b R475 2018
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99446 $2 23
090 $a RC280.L9 $b R433 2018
245 0 0 $a Resistance to ibritumomab in lymphoma $h [electronic resource] / $c edited by Makoto Hosono, Jean-Francois Chatal.
260 $a Cham : $c 2018. $b Springer International Publishing : $b Imprint: Springer,
300 $a xiii, 158 p. : $b ill., digital ; $c 24 cm.
490 1 $a Resistance to targeted anti-cancer therapeutics, $x 2196-5501 ; $v v.18
505 0 $a Clinical Use and Efficacy of Ibritumomab in B-cell Lymphoma -- Biology and Pathology of B-cell lymphoma -- Resistance to Y-90 Ibritumomab Tiuxetan Therapy -- Features of Ibritumomab as Radionuclide Therapy -- Radiological Evaluation of Response and Resistance of Ibritumomab -- Characteristics of Ibritumomab as Radionuclide Therapy Agent -- Resistance and Heterogeneity of Intratumoral Antibody Distribution -- Radiation Dosimetry in Ibritumomab Therapy -- Combining RAIT and immune-based therapies to overcome resistance in cancer? -- Prospects for enhancing efficacy of radioimmunotherapy -- Index.
520 $a This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
650 0 $a Lymphomas $x Treatment. $3 778114
650 0 $a Drug resistance in cancer cells. $3 681914
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Cancer Research. $3 668358
700 1 $a Hosono, Makoto. $3 1203438
700 1 $a Chatal, Jean-Francois. $3 1203439
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Resistance to targeted anti-cancer therapeutics ; $v v.4. $3 1063064
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-78238-6
950 $a Biomedical and Life Sciences (Springer-11642)

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得

Export

取書館別